Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Assembly and infection efficacy of hepatitis B virus surface protein exchanges in 8 hepatitis D virus genotype isolates
Wenshi Wang, Florian A. Lempp, Franziska Schlund, et al.
Journal of Hepatology (2021) Vol. 75, Iss. 2, pp. 311-323
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Hepatitis D virus in 2021: virology, immunology and new treatment approaches for a difficult-to-treat disease
Stephan Urban, Christoph Neumann‐Haefelin, Pietro Lampertico
Gut (2021) Vol. 70, Iss. 9, pp. 1782-1794
Open Access | Times Cited: 174
A Phase 3, Randomized Trial of Bulevirtide in Chronic Hepatitis D
Heiner Wedemeyer, Soo Aleman, Maurizia Rossana Brunetto, et al.
New England Journal of Medicine (2023) Vol. 389, Iss. 1, pp. 22-32
Open Access | Times Cited: 120
Hepatitis D virus-induced interferon response and administered interferons control cell division-mediated virus spread
Zhenfeng Zhang, Yi Ni, Florian A. Lempp, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 4, pp. 957-966
Closed Access | Times Cited: 49
Potent broadly neutralizing antibody VIR-3434 controls hepatitis B and D virus infection and reduces HBsAg in humanized mice
Florian A. Lempp, Tassilo Volz, Elisabetta Cameroni, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 5, pp. 1129-1138
Open Access | Times Cited: 26
HDV RNA assays: Performance characteristics, clinical utility, and challenges
Heiner Wedemeyer, Mitchell Leus, Thomas R. Battersby, et al.
Hepatology (2023)
Open Access | Times Cited: 18
Bulevirtide in the Treatment of Hepatitis Delta: Drug Discovery, Clinical Development and Place in Therapy
Vincent Soriano, Víctor Moreno‐Torres, Ana Treviño, et al.
Drug Design Development and Therapy (2023) Vol. Volume 17, pp. 155-166
Open Access | Times Cited: 15
Different evolutionary dynamics of hepatitis B virus genotypes A and D, and hepatitis D virus genotypes 1 and 2 in an endemic area of Yakutia, Russia
А. А. Карлсен, K. K. Kyuregyan, О. В. Исаева, et al.
BMC Infectious Diseases (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 22
IFITM3 Interacts with the HBV/HDV Receptor NTCP and Modulates Virus Entry and Infection
Massimo Palatini, Simon Müller, Michael Kirstgen, et al.
Viruses (2022) Vol. 14, Iss. 4, pp. 727-727
Open Access | Times Cited: 19
Multiple Regions Drive Hepatitis Delta Virus Proliferation and Are Therapeutic Targets
Jun Zi, Xiuzhu Gao, Juan Du, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 13
Improved hepatitis delta virus genome characterization by single molecule full‐length genome sequencing combined with VIRiONT pipeline
Caroline Charre, Hadrien Regue, Paul Dény, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 3
Open Access | Times Cited: 7
In vitro cell culture models to study hepatitis B and D virus infection
Hongbo Guo, Stephan Urban, Wenshi Wang
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 7
Broad-spectrum activity of bulevirtide against clinical isolates of HDV and recombinant pan-genotypic combinations of HBV/HDV
Roberto Mateo, Simin Xu, Alex Shornikov, et al.
JHEP Reports (2023) Vol. 5, Iss. 11, pp. 100893-100893
Open Access | Times Cited: 7
Human pathogenic RNA viruses establish noncompeting lineages by occupying independent niches
Pascal Mutz, Nash D. Rochman, Yuri I. Wolf, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 23
Open Access | Times Cited: 12
Molecular Epidemiology of Hepatitis D Virus in the North-East Region of Romania
Laura Iulia Grecu, Mariana Pavel, Lilia Matei, et al.
Pathogens (2024) Vol. 13, Iss. 9, pp. 793-793
Open Access | Times Cited: 2
Strain-specific responsiveness of hepatitis D virus to interferon-alpha treatment
Katja Giersch, Paulina Perez-Gonzalez, Lennart Hendricks, et al.
JHEP Reports (2023) Vol. 5, Iss. 4, pp. 100673-100673
Open Access | Times Cited: 5
Management of Delta Hepatitis 45 Years after the Discovery of HDV
S. Brillanti
Journal of Clinical Medicine (2022) Vol. 11, Iss. 6, pp. 1587-1587
Open Access | Times Cited: 8
Cellular Factors Involved in the Hepatitis D Virus Life Cycle
Keerthihan Thiyagarajah, Michael Basic, Eberhard Hildt
Viruses (2023) Vol. 15, Iss. 8, pp. 1687-1687
Open Access | Times Cited: 4
An Insight Into the Factors Affecting the Prevalence and Natural History of Hepatitis D
Zaigham Abbas, Minaam Abbas
Cureus (2023)
Open Access | Times Cited: 4
Prevalence of hepatitis D virus infection in Central Italy has remained stable across the last 2 decades with dominance of subgenotypes 1 and characterized by elevated viral replication
Romina Salpini, Lorenzo Piermatteo, Giulia Torre, et al.
International Journal of Infectious Diseases (2023) Vol. 138, pp. 1-9
Open Access | Times Cited: 4
Antiviral Therapy of Chronic Hepatitis D Virus Infection – Addendum to the S3 Guideline “Prophylaxis, Diagnosis and Therapy of Hepatitis B Virus Infection” of the German Society for Gastroenterology, Digestive and Metabolic Diseases (DGVS)
Lisa Sandmann, Thomas Berg, Katja Deterding, et al.
Zeitschrift für Gastroenterologie (2023) Vol. 61, Iss. 12, pp. e715-e732
Closed Access | Times Cited: 4
Investigating the Genetic Diversity of Hepatitis Delta Virus in Hepatocellular Carcinoma (HCC): Impact on Viral Evolution and Oncogenesis in HCC
Horng‐Heng Juang, Chao‐Wei Hsu, Kang‐Shuo Chang, et al.
Viruses (2024) Vol. 16, Iss. 6, pp. 817-817
Open Access | Times Cited: 1
Novel concepts on mechanisms underlying Hepatitis Delta virus persistence and related pathogenesis
Romina Salpini, Stefano D′Anna, Lorenzo Piermatteo, et al.
Journal of Viral Hepatitis (2022) Vol. 29, Iss. 12, pp. 1038-1047
Closed Access | Times Cited: 7
Treatment of hepatitis delta and HIV infection
Vincent Soriano, Carmen de Mendoza, Ana Treviño, et al.
Liver International (2022) Vol. 43, Iss. S1, pp. 108-115
Open Access | Times Cited: 6
Global Distribution and Natural Recombination of Hepatitis D Virus: Implication of Kyrgyzstan Emerging HDVs in the Clinical Outcomes
Amina Nawal Bahoussi, Peihua Wang, Yanyan Guo, et al.
Viruses (2022) Vol. 14, Iss. 7, pp. 1467-1467
Open Access | Times Cited: 6
Molecular determinants within the C-termini of L-HDAg that regulate hepatitis D virus replication and assembly
Hongbo Guo, Qiudi Li, Chunyang Li, et al.
JHEP Reports (2023) Vol. 6, Iss. 1, pp. 100961-100961
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top